(Q32039141)

5 July 2017

title

Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers (English)

1 reference

5 July 2017

1 reference

1 reference

Fleishaker JC

1

1 reference

5 July 2017

Ryan KK

series ordinal

2

1 reference

5 July 2017

Carel BJ

series ordinal

3

1 reference

5 July 2017

Azie NE

series ordinal

4

1 reference

5 July 2017

publication date

1 February 2001

1 reference

The Journal of Clinical Pharmacology

5 July 2017

published in

1 reference

5 July 2017

volume

41

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

217-223

1 reference

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009917

Migraine prophylactic drugs: proof of efficacy, utilization and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009917

Comorbidity of migraine and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009917

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009917

Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009917

10.1177/00912700122009917

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference